Trend in rifampicin-, multidrug- and extensively drug-resistant tuberculosis in Italy, 2009-2016

Eur Respir J. 2018 Jul 19;52(1):1800070. doi: 10.1183/13993003.00070-2018. Print 2018 Jul.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antitubercular Agents / therapeutic use
  • Emigrants and Immigrants / statistics & numerical data*
  • Extensively Drug-Resistant Tuberculosis / drug therapy
  • Extensively Drug-Resistant Tuberculosis / epidemiology*
  • Humans
  • Italy / epidemiology
  • Mycobacterium tuberculosis / isolation & purification
  • Rifampin / therapeutic use*
  • Tuberculosis, Multidrug-Resistant / drug therapy
  • Tuberculosis, Multidrug-Resistant / epidemiology*

Substances

  • Antitubercular Agents
  • Rifampin